We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.11B
AUM Growth
+$207M
Cap. Flow
+$183M
Cap. Flow %
2.99%
Top 10 Hldgs %
49.09%
Holding
188
New
51
Increased
37
Reduced
33
Closed
43

Top Sells

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$67.4M
2
PTCT icon
PTC Therapeutics
PTCT
+$64.3M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$61.2M
4
BURL icon
Burlington
BURL
+$60.4M
5
ROST icon
Ross Stores
ROST
+$42.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.67%
2 Consumer Discretionary 7.86%
3 Consumer Staples 7.27%
4 Technology 5.96%
5 Communication Services 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTBT icon
51
Bit Digital
BTBT
$482M
$25.6M 0.42%
4,215,852
SAM icon
52
Boston Beer
SAM
$1.93B
$24.2M 0.4%
+48,000
New +$24M
PANW icon
53
Palo Alto Networks
PANW
$296B
$24.2M 0.4%
+261,000
New +$22.6M
BLUE
54
DELISTED
bluebird bio
BLUE
$23.5M 0.38%
117,400
-73,438
-38% -$17.3M
OCDX
55
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$23.4M 0.38%
1,096,000
-1,204,000
-52% -$23.7M
AZN icon
56
AstraZeneca
AZN
$244B
$23.3M 0.38%
+200,000
New +$23.5M
MDLZ icon
57
Mondelez International
MDLZ
$78.1B
$22.9M 0.37%
345,000
-83,000
-19% -$5.12M
CL icon
58
Colgate-Palmolive
CL
$71.7B
$22.9M 0.37%
268,000
-4,000
-1% -$312K
FTDR icon
59
Frontdoor
FTDR
$5.41B
$22.9M 0.37%
+624,000
New +$23.7M
ZBH icon
60
Zimmer Biomet
ZBH
$18.4B
$22.9M 0.37%
185,400
-12,360
-6% -$1.62M
NSTG
61
DELISTED
NanoString Technologies, Inc.
NSTG
$22.6M 0.37%
536,000
-100,000
-16% -$4.37M
RL icon
62
Ralph Lauren
RL
$22.6B
$22.5M 0.37%
+189,084
New +$22.7M
TSVT
63
DELISTED
2seventy bio
TSVT
$21.9M 0.36%
+856,000
New +$26.7M
AXNX
64
DELISTED
Axonics, Inc. Common Stock
AXNX
$21.7M 0.36%
+388,000
New +$23.7M
CRM icon
65
Salesforce
CRM
$153B
$21.6M 0.35%
85,000
+45,000
+113% +$12.6M
SNOW icon
66
Snowflake
SNOW
$109B
$20.8M 0.34%
+61,500
New +$21.4M
ZYME icon
67
Zymeworks
ZYME
$1.64B
$20.5M 0.34%
1,250,197
-1,273,803
-50% -$26.6M
TWNK
68
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$20.4M 0.33%
1,000,000
-800,000
-44% -$14.9M
DECK icon
69
Deckers Outdoor
DECK
$13.6B
$20.2M 0.33%
330,210
-138,642
-30% -$8.94M
NOW icon
70
ServiceNow
NOW
$119B
$20.1M 0.33%
+155,000
New +$20.4M
CVS icon
71
CVS Health
CVS
$133B
$19.8M 0.32%
+192,000
New +$17.7M
LVS icon
72
Las Vegas Sands
LVS
$29.9B
$19.7M 0.32%
+524,000
New +$20.1M
BAX icon
73
Baxter International
BAX
$14.3B
$19.2M 0.31%
224,000
-356,000
-61% -$28.7M
INTU icon
74
Intuit
INTU
$86.5B
$19M 0.31%
+29,500
New +$18.2M
FREE
75
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$18.9M 0.31%
1,756,000
+256,000
+17% +$2.94M

Similar funds

Armistice Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Armistice Capital held 188 positions worth $6.11B, up 3.5% from $5.9B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Armistice Capital's Q4 2021 filing shows 51 new, 37 increased, 33 reduced and 43 closed positions. Its largest new stake was AutoZone: 38,024 shares worth $79.7M. The largest sale was Five Below, an estimated $67.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q4 2021 buy was AutoZone: 38,024 shares worth $79.7M.
  • Armistice Capital added most to Jazz Pharmaceuticals in Q4 2021, an estimated $72.8M increase.
  • Armistice Capital's biggest Q4 2021 reduction was PTC Therapeutics, cutting an estimated $64.3M.
  • Armistice Capital fully exited Five Below in Q4 2021, selling an estimated $67.4M.
  • Armistice Capital's ten largest holdings make up 49% of its $6.11B portfolio in Q4 2021.
  • Armistice Capital opened 51 new positions and closed 43 in Q4 2021.
  • Armistice Capital's portfolio value rose 3.5% quarter-over-quarter to $6.11B.

Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.